Authors: KOREN E MORAWORMS M WARREN MK SZABO JM VADHANRAJ S

Citation: E. Koren et al., ASSESSMENT OF MEGAKARYOCYTE PROLIFERATION CAPACITY IN SARCOMA PATIENTS WHO RECEIVED MYELOID GROWTH-FACTORS FOLLOWING CHEMOTHERAPY, Blood, 90(10), 1997, pp. 3556-3556

Authors: HONGO JAS MORAWORMS M LUCAS C FENDLY BM

Citation: Jas. Hongo et al., DEVELOPMENT AND CHARACTERIZATION OF MURINE MONOCLONAL-ANTIBODIES TO THE LATENCY-ASSOCIATED PEPTIDE OF TRANSFORMING GROWTH-FACTOR BETA(1), Hybridoma, 14(3), 1995, pp. 253-260

Authors: ZIONCHECK TF CHEN SA RICHARDSON L MORAWORMS M LUCAS C LEWIS D GREEN JD MORDENTI J

Citation: Tf. Zioncheck et al., PHARMACOKINETICS AND TISSUE DISTRIBUTION OF RECOMBINANT HUMAN TRANSFORMING GROWTH-FACTOR BETA(1) AFTER TOPICAL AND INTRAVENOUS ADMINISTRATION IN MALE-RATS, Pharmaceutical research, 11(2), 1994, pp. 213-220

Authors: NOBLE PW HENSON PM LUCAS C MORAWORMS M CARRE PC RICHES DWH

Citation: Pw. Noble et al., TRANSFORMING GROWTH-FACTOR-BETA PRIMES MACROPHAGES TO EXPRESS INFLAMMATORY GENE-PRODUCTS IN RESPONSE TO PARTICULATE STIMULI BY AN AUTOCRINEPARACRINE MECHANISM, The Journal of immunology, 151(2), 1993, pp. 979-989